ID

34386

Description

Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver; ODM derived from: https://clinicaltrials.gov/show/NCT01501240

Lien

https://clinicaltrials.gov/show/NCT01501240

Mots-clés

  1. 17/01/2019 17/01/2019 -
  2. 14/05/2019 14/05/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Liver Cirrhosis NCT01501240

Eligibility Liver Cirrhosis NCT01501240

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
Description

ID.1

Type de données

boolean

patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
Description

ID.2

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients under 20 years of age
Description

ID.3

Type de données

boolean

patients who have more than 10 nodules detected on hepatobiliary phase of gadoxetic acid-enhanced mr
Description

ID.4

Type de données

boolean

patients who underwent transarterial chemotherapy or radiofrequency ablation
Description

ID.5

Type de données

boolean

women who are pregnant, lactating or who are of childbearing potential
Description

ID.6

Type de données

boolean

patients with any physical or mental status than interferes with the signing of informed consent
Description

ID.7

Type de données

boolean

patients with a contraindication for mr
Description

ID.8

Type de données

boolean

patients with impaired renal function (e.g. acute renal failure or egfr < 30 ml/min/1.73m2) or patients on dialysis
Description

ID.9

Type de données

boolean

Similar models

Eligibility Liver Cirrhosis NCT01501240

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
boolean
ID.2
Item
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
patients under 20 years of age
boolean
ID.4
Item
patients who have more than 10 nodules detected on hepatobiliary phase of gadoxetic acid-enhanced mr
boolean
ID.5
Item
patients who underwent transarterial chemotherapy or radiofrequency ablation
boolean
ID.6
Item
women who are pregnant, lactating or who are of childbearing potential
boolean
ID.7
Item
patients with any physical or mental status than interferes with the signing of informed consent
boolean
ID.8
Item
patients with a contraindication for mr
boolean
ID.9
Item
patients with impaired renal function (e.g. acute renal failure or egfr < 30 ml/min/1.73m2) or patients on dialysis
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial